Started By
Message

re: AUPH - Aurinia Pharmaceuticals

Posted on 2/8/18 at 8:46 am to
Posted by bayoubengals88
LA
Member since Sep 2007
18996 posts
Posted on 2/8/18 at 8:46 am to
Also added a new BOD:

quote:

VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global immunology market, today announced the appointment of Joseph P. “Jay” Hagan. to its board of directors. Mr. Hagan is currently the President and Chief Executive Officer of Regulus Therapeutics.

“Jay brings a wealth of business development and commercial experience to our Board,” said Richard M. Glickman, Chief Executive Officer and Chairman of the Board of Aurinia. “He has made significant contributions to the biotechnology industry during his career, and his strategic expertise will prove extremely valuable in the board room.”
Posted by Paul Allen
Montauk, NY
Member since Nov 2007
75266 posts
Posted on 2/9/18 at 11:55 am to
Down to $4.82
first pageprev pagePage 1 of 1Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram